Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy.
Wang X, McIntosh L, Selove WJ, Zivny J, Cerny J. Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy. Leuk Lymphoma. 2021 08; 62(8):2022-2025.